These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1439208)

  • 1. In vitro production of specific antibody by equine peripheral blood mononuclear cells using tetanus toxoid as a recall antigen.
    O'Brien MA; Holmes MA; Duffus WP
    Res Vet Sci; 1992 Sep; 53(2):184-90. PubMed ID: 1439208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine peripheral blood mononuclear cells proliferate in response to tetanus toxoid antigen.
    McKelvie J; Little S; Foster AP; Cunningham FM; Hamblin A
    Res Vet Sci; 1998; 65(1):91-2. PubMed ID: 9769082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses.
    Schnabel CL; Fletemeyer B; Lübke S; Marti E; Wagner B; Alber G
    Front Immunol; 2022; 13():805026. PubMed ID: 35493462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.
    Fernandez V; Andersson J; Andersson U; Troye-Blomberg M
    Eur J Immunol; 1994 Aug; 24(8):1808-15. PubMed ID: 8056039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
    Jahn S; Kiessig ST; Grunow R; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
    Jin NR; Lum LG
    Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC
    Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.
    Lum LG; Burns E; Janson MM; Martin PJ; Giddings BR; Seigneuret MC; Noges JE; Galoforo SC
    J Clin Immunol; 1990 Sep; 10(5):255-64. PubMed ID: 2176226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
    Shiobara S; Lum LG; Witherspoon RP; Storb R
    Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tetanus toxoid-specific memory T cells in equine lymph nodes but not in peripheral blood.
    Frayne J; Stokes CR
    Res Vet Sci; 1995 Jul; 59(1):79-81. PubMed ID: 8525091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diversity of antigen-specific antibodies in humans and in two xenochimeric SCID mouse models.
    Layer A; Tissot JD; Schneider P; Duchosal MA
    Electrophoresis; 2000 Jul; 21(12):2463-75. PubMed ID: 10939460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between immunization and circulating antigen-specific plaque-forming cells.
    Falkoff RJ; Zhu LP; Fauci AS
    Cell Immunol; 1983 Jun; 78(2):392-9. PubMed ID: 6190578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
    Munoz JL; Insel RA
    J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.
    Sabin EA; Araujo MI; Carvalho EM; Pearce EJ
    J Infect Dis; 1996 Jan; 173(1):269-72. PubMed ID: 8537675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal antibodies against tetanus toxoid do not inhibit potency of antibody responses to autologous antigen in newborn rhesus monkeys.
    Veazey RS; Lu Y; Xu H; Ziani W; Doyle-Meyers LA; Ratterree MS; Wang X
    J Med Primatol; 2018 Feb; 47(1):35-39. PubMed ID: 28585307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.